TABLE 4

Differences in in vivo functional residual capacity (FRC) measurements from body plethysmography FRC on each device

Subjects nWIMREMndd v2.00ndd v2.01
AbsoluteRelativeAbsoluteRelativeAbsoluteRelativeAbsoluteRelative
Controls20−0.13±0.46#−3.3±13.0%0.17±0.414.7±11.8%−0.73±0.36−20.6±8.9%−0.36±0.32−10.1±8.4%
Asthmatics9−0.24±0.45−6.8±13.8%0.01±0.390.12±12.0%−0.73±0.59−20.7±15.3%−0.42±0.57−11.2±15.8%
All subjects29−0.17±0.45−4.4±13.1%0.12±0.403.3±11.8%−0.73±0.43−20.6±11%−0.38±0.40−10.5±10.9%

Data presented as mean±sd, unless otherwise stated. Absolute measurements are in litres. WIMR: Woolcock in-house device; EM: Exhalyzer D device; ndd v.2.00: EasyOne Pro LAB device Version 2.00.01.05; ndd v.2.01: EasyOne Pro LAB device analysed in Version 2.01.00.09. #: missing data for one subject.